Introduction

Focal segmental glomerulosclerosis (FSGS) is a histologic pattern that is the most common glomerular cause of end stage renal disease (ESRD) in the United States (1).
It is characterized by sclerosis of parts (segmental) of some (focal) glomeruli. There is typically evidence of collapse of capillary loops and increased mesangial matrix deposition in segments of a portion of glomeruli. FSGS histologic lesion is found in about 35% of all cases, and 50% of African Americans, with nephrotic syndrome (2) .
There is a trend of increasing incidence of FSGS caused ESRD in the United States (3) and world (4) .
The Columbia morphological classification defines the collapsing variant, tip variant, perihilar variant, cellular variant and classical or NOS (not otherwise specified) FSGS (5, 6) . It is also possible to cluster FSGS into six clinical types based on etiology (7), which includes the less common medication or infection associated FSGS. Adaptive FSGS results from glomerular hyperfiltration, which can be associated with low birth weight, morbid obesity or sickle cell anemia. Another type is idiopathic, or primary FSGS, with no known cause. In addition, one can define two types of FSGS with a clear genetic basis. First, there are high penetrance genetic causes, with over 38 genes now identified, where homozygous mutation of a single gene results in FSGS (7) . These are more likely seen in childhood nephrotic syndrome (~60%) than in older children or adolescents (~5%), with still lower rates in adults (8, 9) . Causative genes include Actn4, Inf2, Trpc6, and Nphs2, to name a few (7) .
A second genetic cause category involves multiple mutant allele combinations that contribute to FSGS with lower penetrance. For example, genetic variants of Apol1 are a major contributing factor to FSGS in individuals of sub-Saharan descent, being associated with 72% of cases (10) . The effect is mostly recessive, with two risk alleles required, but penetrance is low, as most individuals with two risk alleles will not develop FSGS. Presumably additional environmental and/or genetic contributions are required.
Indeed, it is generally thought that monogenic disease is relatively rare compared to multifactorial (multiple mutant genes combined with environmental causes) and polygenic (mutations in multiple genes) disease. The cumulative effects of several mutations in different genes can combine to cause FSGS or modulate its severity. For example, homozygous MYO1E mutation is associated with childhood FSGS (11) , while coinheritance of mutations in both COl4A5 and MYO1E can dramatically accentuate disease severity (12) .
It has also been shown in mouse models that there can be combined polygenic contributions to FSGS. Cd2ap is a scaffold protein located in the slit diaphragms of podoctyes where it interacts with nephrin and podocin (13, 14) . Homozygous mutation of Cd2ap has been shown to cause high penetrance FSGS in humans (15, 16) . Mice with homozygous mutation of Cd2ap also develop FSGS like disease, with severe nephrotic syndrome, extracellular matrix deposition, glomerulosclerosis, extensive podocyte foot process effacement, and death within weeks of birth (13) . The phenotype of heterozygous mice with only one Cd2ap mutation, however, is "relatively unremarkable" (17) , with some glomerular changes noted at 9 months of age (18) . Fyn encodes a tyrosine kinase, related to Src, that phosphorylates the slit diaphragm component Nephrin (19) . Heterozygous mutation of Fyn gives rise to very rare proteinuria, while homozygous Fyn mutation results in proteinuria in only 31% of mice at an average onset of 8 months (17) . Of interest, however, combined Cd2ap+/-, Fyn-/-mice develop proteinuria in 100% of mice at average onset of only 5 months (17) . This synergy of phenotype represents a combined susceptibility allele model. A fraction of human FSGS cases also likely result from multiple mutant alleles, in various mixes of susceptibility genes, together increasing the chances of FSGS. In this report we further study the Cd2ap+/-, Fyn-/-bigenic murine model of FSGS, examining gene expression changes that take place in the glomerular podocyte, mesangial and endothelial cells.
Podocyte injury plays a key role in the initiation and progression of glomerular disease, including FSGS (20) . The first detectable morphological characteristics of FSGS are found in podocytes (21) , which undergo hypertrophy, detachment from the glomerular basement membrane (GBM), effacement of foot processes and depletion in number.
The other two main glomerular cell types, however, the mesangial and endothelial cells, also undergo dramatic changes during FSGS. There is, for example, mesangial expansion with increased extracellular matrix, and endothelial cells can show increased leukocyte recruitment (22) as well as de novo angiogenesis, which can result in leaky vessels (23) . A comprehensive analysis of FSGS, therefore, requires examination of mesangial cells and endothelial cells as well as podocytes.
The current Kidney Disease: Improving Global Outcome (KDIGO) practice guidelines link therapy to pathology. Initial treatments include inhibitors of the renin-angiotensin system and corticosteroids. Steroid resistant patients can be treated with cyclosporine, mycophenolate mofetil, or tacrolimus, with responses varying for different types of FSGS. Nevertheless, a high percentage of patients prove unresponsive to all available therapies, emphasizing the need for a deeper understanding of FSGS to guide the development of improved treatment options. In this report we define the activated pathogenic and protective molecular pathways in each major cell type of the glomerulus in the bigenic Cd2ap+/-, Fyn-/-mouse model of FSGS, thereby providing a global view the disease process that might aid in the identification of novel therapeutic targets.
Materials and Methods
Mouse Strains
The Cd2ap mutant (B6.129X1-Cd2ap tm1Shaw /J), Tie2-GFP (Tg[TIE2GFP]287Sato/J) and Fyn (B6.129-Fyn tm1Sor /J) mice were obtained from the Jackson Laboratory. MafB-GFP, Tg (MafB-EGFP) FT79Gsat and Meis1-GFP Tg (Meis1-EGFP) FO156Gsat, were from GENSAT/MMRC (http://www.gensat.org).
Animal Ethics
All animal experiments were carried out according to protocols approved by the Cincinnati Children's Medical Center Institutional Animal Care and Use Committee (protocol title "mouse models of focal segmental glomerulosclerosis", number 2016-0020).
Single Cell Prep for FACS Sorting
Mice were euthanized via cervical dislocation after sedation with isoflurane; kidneys were isolated and placed into ice-cold PBS. Glomeruli were isolated as previously described (24) . For isolating podocytes, a single cell suspension was derived from the glomeruli as previously described (24) . Briefly, the glomeruli were incubated for 40 minutes in 2 mL enzymatic digest buffer (Containing Type 2 collagenase 300 U/mL, 1 mg/mL pronase E, 50 U/mL DNAse 1) at 37˚ C while shaking at 1400 RPM/min in a thermomixer. Every 10 minutes the digestion mix was passaged two times with a 27-gauge needle (25) . After digestion, equal volume ice-cold 10% FBS/PBS was added and the cells were triturated.
The cells were filtered using a 40 µM filter to remove clumps, pelleted by centrifugation, rinsed with ice-cold 1% FBS/PBS, re-suspended in 400 µL 1% FBS/PBS and filtered using a 35-µM filter mesh prior to FACS sorting. GFP-positive cells were collected in Buffer RL. After collection, the lysate was vortexed and placed on dry ice.
Target Cell Isolation
The Meis1-GFP, MafB-GFP, and Tie2-GFP transgene reporters enabled FACS-sorting Table 1 . Average ages of mice used for analysis.
RNA Purification, Amplification and Sequencing
For mesangial and endothelial samples, we purified the RNA using Zymo ZR MicroPrep Kit (cat. # R1061) with in-solution DNAse treatment. Due to a lower yield of cells for 3-allele MafB-GFP selected podocytes (due to podocyte cell loss), we used the Norgen Single Cell RNA Purification Kit (cat. # 51800) with on-column DNAse treatment for both the podocyte control and 3-allele samples.
The initial amplification step for all samples was done with the NuGEN Ovation RNASeq System v2. The assay was used to amplify RNA samples to create double stranded cDNA. The concentrations were measured using the Qubit dsDNA BR assay. Libraries were then created for all samples. Specifically, the Illumina protocol, the Nextera XT DNA Sample Preparation Kit, was used to create DNA library templates from the double stranded cDNA. The concentrations were measured using the Qubit dsDNA HS assay.
The size of the libraries for each sample was measured using the Agilent HS DNA chip.
The samples were placed in a pool. The concentration of the pool is optimized to acquire at least 15-20 million reads per sample. Sequencing was performed on the Illumina HiSeq2500, single-end 75 base pair. Sequencing data is available in the Gene Expression Omnibus (GEO), accession number GSE123179.
RT-qPCR Validations
Glomeruli were isolated from 3-allele and control mice using the sieving method described previously (24) . Glomeruli were then lysed by addition of Buffer RLT, vortexing and then placing the tubes on dry ice. RNA was purified using the Qiagen RNEasy Micro Kit (cat. # 74004). RNA was quantified using a NanoDrop spectrophotometer (NanoDrop Technologies, DE, USA). The quality of the RNA was analyzed using an Agilent Bioanalyzer (nano-chip). RNA Integrity Numbers (RIN) were > 8.0. Reverse transcription reactions were set up using the RT-VILO SuperScript cDNA synthesis kit from Invitrogen (cat. # 11754-050). The cDNA was then precipitated by adding 2 µL of 3 M sodium acetate, 1 µL glycogen and 57.5 µL 100% ETOH for a total volume of 80.5 µL. Following overnight incubation at -20 ˚C, the cDNA was pelleted at 14,000 RPM for 20 minutes at 4˚ C. The pellet was rinsed with 70% ETOH, decanted and left to air dry. The cDNA was re-suspended in 51 µL H 2 0 and then quantified using a NanoDrop spectrophotometer set to measure single-stranded DNA. RT-qPCR was performed using the PowerUp SYBR Green Master Mix (Applied Biosystems, cat. # A25742) and the StepOnePlus using the relative standard curve method. Samples were normalized to beta-actin (mesangial and endothelial genes) or nephrin (podocyte genes).
RT-qPCR Primer Design
Genes were selected based on restricted up-regulation in one sorted glomerular 3-allele cell type compared to control cells, or in the case of Serpine1 up-regulation in several cell-types. RT-qPCR primers were designed using Primer-Blast to amplify a product size between 75 and 200 bp using the mRNA RefSeq database of Mus musculus.
Where possible, the primers were designed to span an intron. Primers used are listed below in Table 2 . Table 2 . Primer sequences used for RT-qPCR validations.
Gene Forward Primer Reverse Primer
RNA-seq Data analysis
RNA-seq data was analyzed using Strand NGS 3.2. The reads were aligned to mm9.
Reads were quantified using DeSeq with normalization threshold of 1. The baseline was set to the median of all samples.
Filtering gene lists (all samples):
Reads were filtered based on genic region; spliced, partial genic, exonic, exon intron junction and genic reads were retained; intergenic and intronic reads were removed.
Reads were further filtered on read quality metrics with the following parameters:
Quality threshold >= 20, N's allowed in read <=0, number of multiple matches allowed <= 1, and reads were removed that are failing vendor's QC. Duplicate reads were removed, with a threshold of 4.
Generating gene lists comparing podocytes, mesangial cells, endothelial cells and controls:
At least 5.0 NRPKM in 3 out of 6 samples was required. A moderated t-test was then used to compare 3-allele and control samples with a corrected p-value cut-off of 0.05.
The p-value computation was asymptotic and no multiple testing correction was used.
This list was then used to perform a fold-change analysis between 3-allele and control samples, with a fold-change cut-off of >= 1.5. Y-linked genes, associated with sex differences between the samples, were removed from the final gene list.
Filtering endothelial genes from MafB-GFP podocyte samples
For the podocytes, in order to remove the effects of a small percentage of contaminating endothelial cells, the WT glomerular endothelial cells were compared with WT podocytes. At least 80 NRPKM was required in 2 out of 6 samples (podocyte or endothelial); the cell types were compared with Audic Claverie test with no multipletesting correction and a p-value cut off of 0.05. A fold change>=4 in endothelial cells compared to podocytes was used to generate a list of genes with high specific expression in endothelial cells. This list of genes was compared using a Venn diagram with differentially expressed podocyte (MAFB) genes. Genes were excluded from the list of differentially expressed MAFB genes which were found in both the MAFB list and the list of genes up-regulated in endothelial cells.
Heat map parameters:
The heat map was generated within Strand NGS software using a hierarchical clustering algorithm and clustered by normalized intensity values. The heat map was clustered on entities and conditions. The similarity measure is Pearson Centered. The linkage rule is Ward's. There was no clustering within conditions.
Results and Discussion
In this study we used RNA-seq to define the altered gene expression patterns of each major cell type of the glomerulus in the Cd2ap+/-, Fyn-/-bigenic mouse model of FSGS.
To isolate the podocytes, mesangial cells and endothelial cells from the control and mutant FSGS kidneys we used three different transgenic reporter mouse lines. MafB-GFP, Meis1-GFP and Tie2-GFP which drive cell type restricted GFP expression in the podocytes, mesangial cells and endothelial cells of the glomerulus, respectively (24).
We first isolated glomeruli, using a sieving protocol, and then used further enzymatic dissociation to produce single cell suspensions. By combining the three mutant alleles (Cd2ap+/-, Fyn-/-) with the appropriate GFP transgene reporter it was possible to purify the podocytes, mesangial cells and endothelial cells by fluorescent activated cell sorting (FACS). We then examined the FSGS altered gene expression patterns of all three major glomerular cell types using RNA-seq to begin to better understand the underlying pathogenic molecular pathways.
Cd2ap+/-, Fyn-/-Phenotype
In agreement with previous studies, we observed the onset of proteinuria at around 5 months of age in the Cd2ap+/-, Fyn-/-mice, with near 100% penetrance (17) . H&E and Jones Silver Stain were used to characterize the FSGS like pathology observed in the Cd2ap+/-, Fyn-/-glomeruli ( Fig. 1 ). There were localized regions of scarring in some glomeruli, as well as capillary lumen loss and increased mesangial matrix. Scanning EM of the Cd2ap+/-, Fyn-/-glomeruli showed podocyte depletion, fusion of foot processes and general disorganization of remaining podocytes (Fig. 2) . Transmission EM further showed the altered podocyte foot process structures and, of interest, regions of expanded GBM (Fig. 3) . At the time of sacrifice, around 11 months, the Cd2ap+/-, Fyn-/-mice showed normal serum creatinine, elevated serum BUN (33.6 mg/dL versus 26.2 mg/dL for control, P = 0.0001), and decreased serum albumin (2.58 g/dL versus 2.89 g/dL for control, P = 0.03). 
Assaying cell type purity
The isolation of strongly enriched populations of glomerular cell types can be challenging. The podocytes, in particular, are tightly wrapped around capillary loops with extensively interdigitated foot processes attached to the glomerular basement membrane. The mutant podocytes, within partially sclerotic glomeruli, were particularly challenging to detach.
We used two metrics to assay enrichment levels for the three cell types following FACS.
The first was enriched expression levels of expected cell type specific marker genes. By this measure all FACS cell preparations showed strongly elevated expression of predicted markers, indicating robust enrichment of desired cell types. For example, Nphs2 expression is an excellent marker for the podocyte, and all six podocyte cell preparations, including three Cd2ap+/-, Fyn-/-mutant and three control, showed very high expression levels of Nphs2, in the range of 1,400-2,300 RPKM.
A second and more stringent metric is to look for the expression levels of marker genes associated with potential contaminating cell types. By this measure, for example, the endothelial and mesangial cell preparations were very free of podocyte contamination, with podocyte marker Nphs2 expression levels of only 0, 0, 0, 0, 4 and 1 RPKM in the six endothelial cell preparations and 0, 2, 0, 1, 1, and 11 RPKM in the mesangial cell preparations. In similar manner the mesangial cells were essentially free of endothelial contamination and the endothelial cells also free of mesangial contamination.
The podocytes, however, showed detectable levels of cross contamination. For example, the endothelial expressed gene Kdr, gave an average expression level of 336 RPKM in endothelial cell preparations and 15 RPKM in podocytes, suggesting a low level of contamination. The bioinformatics analysis pipeline was therefore modified for podocytes to take this into account, as described in Material and Methods.
Podocytes
As previously mentioned, to define the gene expression pattern of mutant podocytes we made Cd2ap+/-, Fyn-/-mice that also carried the MafB-GFP transgene, which gives GFP expression specifically in podocytes in the developing kidney (26) . Glomeruli were purified, from mutants and controls, dissociated to give single cell suspensions, and podocytes isolated by FACS. RNA was purified and used for RNA-seq, and the resulting data analyzed with Strand NGS software.
There were many significant gene expression changes in the Cd2ap+/-, Fyn-/-podocytes, compared to controls, with 90 genes up-regulated greater than 2 fold change (FC) and 29 genes down-regulated (> 2 FC) (Table S1 ). A heatmap showing gene expression changes in bigenic mutant podocytes compared to controls is shown in Fig. 4 , with an expandable version including gene names provided (Fig. S1 ).
Fig. 4. Heatmap showing gene expression changes in control (ctrl) versus
Cd2ap+/-, Fyn-/-three allele mutant (3A) podocytes. There were three samples of each, with red indicating stronger expression and blue indicating weaker expression.
Genes with greater than 2 fold change are shown. An expandable version including gene names is included in supplementary data (Fig. S1) . Lists of genes with fold change are included in Table S1 .
Growth factor related genes with elevated expression in mutant podocytes included (27), driving branching morphogenesis of the ureteric bud, which expresses the Gdnf receptor Ret. Gdnf is a member of the Tgf superfamily. Of particular interest, Gdnf has been shown to be a survival factor in injured podocytes, acting in an autocrine manner (28) .
The increased expression of Tgf1, Tgf2, Vegfb and Bmp4, additional members of the Tgf family, give evidence for a role for podocytes in driving fibrosis, since Tgf has been shown to be a major mediator of fibrosis (29, 30) . Bmp4 has been shown to play a profibrotic role in the liver (31) , and to drive expression of the fibrosis related gene Acta2 in hepatocyte stellate cells (32) . Of note, we did also observe in the mutant podocytes strong upregulation (8.2 FC) of Acta2, a classic smooth muscle marker associated with myofibroblasts. During fibrosis many cell types can differentiate into myofibroblasts (33) .
We also observed the upregulation of Arid5b (1. Tenascin-C (Tnc) showed ~22 fold elevated expression in mutant podocytes. Tenascin-C is a multifunctional extracellular matrix protein that is upregulated during wound healing, with persistent expression observed in a variety of chronic pathological conditions (37) . Importantly, Tnc expression in fibroblasts drives a fibrotic response, once again including upregulation of Acta2 expression (38) . Further, there is a dramatic attenuation of lung fibrosis in bleomycin treated mice carrying homozygous mutation of Tnc (38) . Tnc expression is upregulated by Tgf in fibroblasts through Alk5 mediated Smad2/3 signaling (38) . Tnc promotes secretion of Tgf, which in turn promotes expression of Tnc, resulting in yet another a feed forward loop (38) .
Tnc transcripts undergo extensive alternative splicing, potentially giving rise to hundreds of different isoforms (39) . In addition, the Tnc protein undergoes many variable post translational modifications, further contributing to its observed considerable functional diversity. Tnc can bind multiple ligands including fibronectin, contactin, glypican, and integrins (39) , and can also activate epidermal grown factor receptor (40) Another highly upregulated gene in the mutant podocytes was Spon2 (135 FC), which encodes an extracellular matrix protein that is critical for inflammatory cell recruitment (50) , efficient dendritic cell priming of T-lymphocytes (51) and trafficking of eosinophils (52), suggesting an important role in driving the immune response. Fxyd5 (9.6 FC), encoding the gamma subunit of the Na,K-ATPase, as well as Atp1b1 (9.4 FC), encoding the beta chain of Na,K-ATPase were also increased in expression in mutant podocytes.
Sost, encoding sclerostin, was also strongly upregulated (10 FC) in mutant podocytes. It is a BMP antagonist, perhaps counteracting in some measure the observed upregulation of Bmp4.
GO analysis of the list of genes upregulated in the mutant podocytes identified elevated protein kinase activity and increased expression of growth factors as the most significant molecular functions. The most strongly impacted biological process was negative regulation of cell adhesion (P = 4.26E-9), likely related to FSGS loss of podocytes. Other upregulated biological processes were cell motility (P = 7.8E-9) and programmed cell death (P = 3.5E-8). The observed apoptosis gene expression signature in the mutant podocytes, with for example elevated expression of Casp4 (5.8 FC), is also consistent with the well-defined podocyte depletion in FSGS (53, 54) . Fig. 5 shows a cytoscape with multiple identified functionalities and associated genes. Table S1 ). The Pamr1 gene has been associated with muscle regeneration (56) , which is of interest given the contractile nature of the podocyte (57), perhaps playing a role in counteracting the perfusion pressure of the capillaries. Nevertheless, the gene expression signature of the podocyte shows only a weak muscle signature (26) .
Mesangial cells
Mesangial expansion is a hallmark of FSGS, with increased extracellular matrix and mesangial cell proliferation. The Cd2ap+/-, Fyn-/-mutant mesangial cells showed upregulation of 55 genes (>1.5 FC) compared to control (Table S2 ). One of the upregulated genes (4.3 FC) with strong expression, over 100 RPKM in mutants, was
Aldh1a2, involved in the synthesis of retinoic acid, similar to Aldh1a1, which was upregulated in podocytes.
Thrombospondin (Thbs1, 3.8 FC) was strongly upregulated in mutant mesangial cells.
Thbs plays an important role in the activation of Tgf, which is secreted in inactive pro- It was interesting to find that in some cases the same pathway was activated in both podocytes and mesangial cells. It has also been shown that Prss23 can promote TGF signaling during zebrafish cardiac valve formation as well as in human aortic endothelial cell assays (62) .
There were relatively few down regulated genes in Cd2ap+/-, Fyn-/-mutant mesangial cells, with only six with greater than 2 FC, and all of these showing low expression levels, even in controls (Table S2 ).
Endothelial cells.
The endothelial cells are the third major cell type of the glomerulus. They can also play a role in the progression of FSGS through the production of growth factors and cytokines, leaky angiogenesis, and the recruitment of macrophages and leukocytes. (Table S3) .
Upregulated genes included Apnlr encoding a G-coupled receptor for Apelin that inhibits adenylate cyclase and is implicated in angioblast migration and regulation of blood vessel formation. Also upregulated was Kctd10, which binds proliferating cell nuclear antigen (PCNA) and may be involved in DNA synthesis and cell proliferation and is also involved in ubiquitination.
Another upregulated gene in mutant endothelial cells was Nestin, which encodes an intermediate filament protein and is normally associated with neural stem/progenitor cells. It is, however, also expressed in endothelial cells in pancreas (63) , in ovary and placenta (64) , as well as vascular neoplasms (65) and cancers (66) , where is a marker of neovasculature.
GO analysis for mutant endothelial cell upregulated genes found biological processes including negative regulation of response to oxidative stress, negative regulation of cell death and lymphocyte aggregation.
QPCR Validations
The RNA-seq results were validated using RT-QPCR. Glomeruli from three mutant allele Cd2ap+/-, Fyn-/-and control mice were isolated using a sieving procedure (24), RNA purified and used for RT-QPCR. Genes were selected based on restricted upregulation in mutants in one sorted glomerular cell type compared to control cells.
Samples were normalized to beta actin (actb) for mesangial and endothelial genes, or nephrin (Nphs2) for podocyte genes. RT-QPCR validated upregulation of Endou, Parm1, Serpine1, Spon2, and Rspo1 in mutant podocytes, and Cpe, Aldh1a2, Tnc, Cpne7, Frzb, and Thbs1 in mutant mesangial cells (Fig. 6) . 
Conclusions
